clinical trials
trial name
conditions
enrollment ends
Adjuvant immunotherapy combination with losartan/toceranib/ladarixin for non-metastatic osteosarcoma
osteosarcoma
Asparaginase, procarbazine, prednisone, and lomustine for canine multicentric lymphoma
lymphoma
CAR T cell immunotherapy for treatment of metastatic osteosarcoma in dogs
osteosarcoma
Combination therapy with gilvetmab and toceranib in dogs with mast cell tumors
mast cell tumor
Combination trametinib and sapanisertib for canine malignant neoplasia
neoplasia
COTC027: Preclinical Comparison of Two Hypomethylating Nucleosides in Tumor-Bearing Dogs
solid tumor
COTC031: Novel immune therapy for dogs with lymphoma or solid tumors
solid tumor
COTC033: Repurposing vaccine immunity to treat cancers, validation in canine patients
neoplasia
Evaluation of adaptation time in dogs undergoing limb amputation for osteosarcoma
osteosarcoma
Focal adhesion kinase inhibition to improve losartan-toceranib immunotherapy in canine metastatic osteosarcoma
osteosarcoma
Lattice radiation therapy’s effect on the immune response in canine sinonasal carcinoma
sinonasal carcinoma
Local immune response to radiation therapy and combined myeloid cell targeted therapy in a dog model of sinonasal carcinoma
sinonasal carcinoma
Novel therapy with LSD-1 inhibitor for cats with oral squamous cell carcinoma
oral squamous cell carcinoma
Oral melanoma study in dogs
oral melanoma
Palliative radiation therapy with or without bisphosphonates or carboplatin for dogs with osteosarcoma
osteosarcoma
Pharmacokinetics of compounded chlorambucil in cats with cancer
small cell lymphoma
Phase I clinical trial of NIH 972 in dogs with spontaneously occurring sarcomas
sarcoma
Phase-1 evaluation of vismodegib plus carboplatin in dogs with spontaneous osteosarcoma
osteosarcoma
Single-dose plasma pharmacokinetic analysis of targeted anticancer agents in tumor-bearing dogs
malignant neoplasia
The effect of intravenous carboplatin on pain control in dogs with appendicular osteosarcoma
osteosarcoma